Teva Pharmaceuticals @TevaUSA
We’re pleased to announce a consensus statement published in the Journal of Clinical Psychiatry highlighting a first-of-its kind, standardized tool to measure the impact of #tardivedyskinesia on patients’ daily function. Learn more: https://t.co/sQ11dCjMW3 https://t.co/XMawAnqOEQ — PolitiTweet.org